Professor Simon Roger
Renal Unit, Gosford Hospital
Dr Amali Mallawaarachchi
Royal Prince Alfred Hospita
Professor Lisa M. Guay-Woodford
Children’s National Medical Center (CNMC)
Dr Muh Geot Wong
Royal North Shore Hospital & University of Sydney
Professor Yusuke Suzuki
Juntendo University, Tokyo, Japan
Dr Lisa Jeffs
Royal Hobart Hospital
Professor Roger is a Consultant Nephrologist and Director at the Renal Unit, Gosford Hospital, Gosford, Australia.
He trained initially at Westmead Hospital in Sydney, then researched at St Bartholomew’s Hospital, London, subsequently receiving his Doctorate of Medicine degree from the University of New South Wales, Australia.
Professor Roger now has over 30 years’ experience researching anaemia and the role of iron in patients with chronic kidney disease. He lectures widely in this field and has been an invited lecturer at numerous national and international congresses and meetings. He has also participated in a number of advisory boards, where he has shared his expertise in the management of anaemia and iron therapy.
He has contributed to a number of clinical trials assessing new anaemia treatments and the role of iron in patients with chronic kidney disease, both through his role as Principle Investigator and as an active Steering Committee member. In addition, he is also a member of several medical associations, including the Australian and New Zealand Society of Nephrology, the International Society of Nephrology.
Lastly, Professor Roger has authored or co-authored over 90 journal articles, including papers the NEJM, JAMA, KI, NDT and AJKD and has contributed to the development of national and international guidelines including Caring for Australians with Renal Insufficiency (CARI Guidelines): Target Haemoglobin and Iron and the 2008 Kidney Disease: Improving Global Outcomes (KDIGO) guideline.
Dr. Lisa M. Guay-Woodford is the McGehee Joyce Professor of Pediatrics at the Children’s National Medical Center (CNMC), a pediatric nephrologist, and an internationally-recognized investigator whose research focuses on identifying clinical and genetic factors involved in the pathogenesis of inherited renal disorders, most notably autosomal recessive polycystic kidney disease (ARPKD). Her laboratory has identified the disease-causing genes in several mouse models of recessive polycystic kidney disease and her group participated in the identification of the human ARPKD gene as part of the ARPKD Consortium. In addition, her laboratory was the first to identify a candidate modifier gene for recessive polycystic kidney disease. Dr. Guay-Woodford has over 140 peer-reviewed publications based on research performed in her own laboratory or as a member of several national and international consortia. She has directed the NIDDK P30-funded Hepato-Renal Fibrocystic Disease Research and Translational Core Center, initially established at the University of Alabama at Birmingham in 2005, and continues to serve as co-Director since moving to CNMC in 2012. Her research program has been funded by the NIH, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, and the Polycystic Kidney Disease Foundation. In 2009, Dr. Guay-Woodford was awarded the Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease, given by the PKD Foundation and the International Society of Nephrology.
In addition to her investigative work, Dr. Guay-Woodford has established and serves as Director of the CNMC Inherited Renal Disorders Program. She is the Director of the Center for Translational Science, as well as Director of the Clinical and Translational Science Institute at Children’s National Medical Center (CTSI-CN), which is funded by the NIH CTSA program. She serves on several editorial boards for journals in her field. She has been a permanent member and Chair of the NIH Cellular and Molecular Biology of the Kidney Study Section. She is the Past President of the Society for Pediatric Research and Councilor for the International Pediatric Nephrology Association. She has served as a Board of Trustee member for the Polycystic Kidney Disease Foundation as well as the Association of Clinical and Translational Science. She currently serves as a member of the National Institute of Diabetes and Digestive and Kidney Diseases Advisory Council.
Dr Wong obtained his MBBS in 2000 follows by MRCP (UK) and Nephrology training in Malaysia before migrating to Australia where he obtained his Fellowship in Nephrology and a PhD in Medicine from the University of Sydney in 2010. He is currently a Renal Staff Specialist at the Royal North Shore Hospital (RNSH), and a Senior Clinical Lecturer of University of Sydney and University of NSW. He is a Clinician Researcher through his capacity as the Senior Research Fellow at the Kolling Institute and the George Institute for Global Health. He pursues a strong interest in research in understanding the pathomechanism of kidney fibrosis and has actively promoted the development of both clinical and pre-clinical research in delaying CKD progression in diabetic nephropathy, IgA nephropathy and management of cardiovascular complications associated with CKD. He currently serves as the Head of the Renal Clinical trial unit at the RNSH and Co-Chair of the Research Group for the Chronic and Complex Medicine Network for Northern Sydney Lower Health District (NSLHD). He is the program Chair of the Nephrology and Transplantation Update Course for the Scientific Program and Education Committee (SPEC), ANZSN, and recently becomes a member of the Asia Pacific Society of Nephrology (ASPN) CME Committee and invited to be the Program Co-chair for the Nephrology Biennial Review Course, for the WCN in Melbourne, 2019. He was elected as the Deputy Chair of the Oceania South East Asia Regional Board, International Society of Nephrology (ISN). He is a member of the KHA-CARI guideline writing group for “Infection control for haemodialysis unit” and the Working Group for Clinical Practice Guidelines for Diabetic Nephropathy for the APCN focusing on lower and middle income countries. He is the Subject Theme Editor for Journal Nephrology.
Yusuke Suzuki is currently Professor of Department of Nephrology in Graduate School of Juntendo University. His academic positions include Directors of Japanese Society of Nephrology (JSN), Councilor of Japanese Society of Internal Medicine, Japanese Society of Dialysis Therapy, Japanese Society of Hypertension, ISN council, ISN Deputy Chair of North and East Asia Regional Board, Liaison officer in ISN sister renal center program for JSN/Vietnam, Chief Researcher of Special Research Group of IgA Nephropathy in Progressive Renal Diseases Research from the Ministry of Health, Labor and Welfare of Japan, Chief Researcher of biomarker project on IgA nephropathy from Research on Intractable Disease from Japan Agency for Medical Research and Development. His research mainly focused on the pathogenesis of IgA nephropathy. So far, his studies were supported more than 60 scientific research grants. He has more than 130 English publications, including Kidney Int, JASN, J Clin Invest, JAMA Int Med, JAMA Netw, Nat Med. He is now an Editorial Board member for Kidney Int, Nephrology and Kidney Diseases.
Dr Lorraine Kwan
Queen Mary Hospital & Tung Wah Hospital in Hong Kong
Dr Andrea Viecelli
University of Queensland & Princess Alexandra Hospital
Dr Sunita Bavanandan
Hospital Kuala Lumpur, Malaysia
Dr Emily See
Professor Carol Pollock
The University of Sydney
Professor Patrick Mark
Queen Elizabeth University Hospital Glasgow
Lorraine works as associate consultant in the Department of Medicine, in Queen Mary Hospital and Tung Wah Hospital in Hong Kong. She is also honorary tutor at the Li Ka Shing Faculty of Medicine, the University of Hong Kong.
Dr. Kwan received her medical degree from the University of Hong Kong in 2007 and pursued post-graduate training in nephrology in Queen Mary Hospital. She also served as honorary fellow at the Monash Medical Centre in 2017-2018.
Lorraine has extensive clinical experience in the field of peritoneal dialysis, haemodialysis and renal transplantation. She is especially passionate about optimizing haemodiaylsis services and improving patient education on kidney diseases.
Dr Andrea Viecelli is a Senior Lecturer at the Faculty of Medicine, University of Queensland and nephrologist at Princess Alexandra Hospital in Brisbane, Australia. She completed her PhD on strategies to improve vascular access outcomes in patients on haemodialysis through the University of Queensland in 2019. She is a clinical trialist of the Australasian Kidney Trials Network and a lead investigator of the FAVOURED study, an international, multicentre randomised controlled trial of fish oil and aspirin for preventing arteriovenous fistula failure. As a coordinating committee member of the global Standardised outcomes in Nephrology (SONG) initiative, she is leading an international collaborative study (VALID) to validate a standardised core outcome measures for vascular access function. Her research focus is in clinical trials, meta-analyses, and qualitative research in patient-important outcomes. She is an academic editor for PLOS ONE and reviewer for several international high-impact journals. She has published over 30 peer-reviewed articles, 5 book chapters and received numerous awards, including a Kidney Health Australia Clinical Science Award and a Young Investigator Award at the Australian and New Zealand Society of Nephrology Annual Scientific Meeting in 2016 and 2017, and two Young Investigator Award at the ERA-EDTA congress in 2017 and 2018, respectively.
Dr.Sunita Bavanandan graduated from the University of Queensland Australia in December, 1991. She obtained her qualifications as a Member of the Royal College of Physicians United Kingdom in 1997 and became a Fellow of the Royal College of Physicians Edinburgh in 2007. From 2003-2004 she obtained further training at the Leicester General Hospital, United Kingdom. Special interests are in Chronic Kidney Disease, Hypertension, Diabetic Kidney Disease and Peritoneal Dialysis.
She has been a member of several Malaysian Guidelines Development Committees including CPG on Management of Hypertension ( 3rd to 5th editions), CPG on Management of Chronic Kidney Disease in Adults ( 1st and 2nd editions) and CPG for the Management of Heart Failure 2019.
She contributes as an editor/author for chapters in the Malaysian Dialysis & Transplant Registry and the Malaysian Registry of Renal Biopsy. She is a Member of the Southeast Asia Glomerulonephritis Network and is involved in setting up the regional Southeast Asian PD registry (PROMISE) .
She is the current President of the Malaysian Society of Nephrology and is the Head of the Department of Nephrology, Hospital Kuala Lumpur, Malaysia .
Emily See is a Critical Care Nephrologist and Research Fellow in the Department of Intensive Care at Austin Health, Melbourne. She completed her renal training at University Hospital Geelong, Princess Alexandra Hospital, and Monash Health, and is currently undertaking a PhD examining the long-term sequelae of acute kidney injury, with the aim of developing an evidence-based model of care for high-risk survivors. Her other clinical interests include renal replacement therapy for acute and chronic kidney diseases, ultrafiltration rate and volume management in haemodialysis, and the diagnosis and management of complement-mediated thrombotic microangiopathies. She is an active member of several academic groups, including the steering committee and renal biopsy guideline group of KHA CARI and the haemodialysis working group of the ANZDATA Registry. She has published over 20 peer-reviewed articles and 3 book chapters, acts as a reviewer for several high-impact journals in the fields of nephrology, critical care, and internal medicine, and has received 5 national and international awards for clinical and basic science research. She has a strong interest in medical statistics and clinical epidemiology and is completing an MSc in Medical Statistics through the University of Oxford, investigating novel methodology for clinical risk prediction in chronic disease.
Carol Pollock is an academic nephrologist with over 330 publications in basic research and clinical medicine, with an H index of 61 and over 18,750 citations. She is an inaugural Fellow of the Australian Academy of Health and Medical Sciences (2015), was conferred a Vice Chancellors Award for Excellence in Research Supervision (2012) and recognised as a ‘Distinguished Professor’ by the University of Sydney (2012). She was the 2014 recipient of the Ministerial Award for Excellence in Cardiovascular Research. She was Scientific Chairman of the 2013 World Congress of Nephrology, held in Hong Kong. She is Chair of Kidney Health Australia, Deputy Chair of the Board of the Australian Organ, Tissue and Transplant Authority; Chair of the NSW Cardiovascular Research Network and inaugural Chair and then co-chair of the Research Advisory Committee of the Australian and New Zealand Society of Nephrology. She was appointed to NHMRC Council by Minister Greg Hunt in 2018. Health leadership roles include inaugural Chair of the NSW Agency for Clinical Innovation, immediate past Chair of the NSW Clinical Excellence Commission, remaining as a director of both organisations till April 2016. She was Chair of the Northern Sydney Local Health District Board since its inception in 2011 till Dec 2016, was appointed to the Board of the NSW Bureau of Health Information in April 2016 and assumed Chairmanship of the Bureau in November 2016. She is the current Convenor of the NSW Council of Board Chairs of Local Health Districts and Specialty Networks. She is on the scientific advisory committee of Australian Biotech Company Pharmaxis Pty Ltd, is a Director of Certa Therapeutics and a clinical advisor to Quantium Health. In November 2018 she was made an Ambassador of Business Events Sydney.
Patrick (Paddy) Mark is Professor of Nephrology and Honorary Consultant Nephrologist at the Glasgow Renal and Transplant Unit based at the Queen Elizabeth University Hospital Glasgow. He was appointed as Clinical Senior Lecturer in 2011 following clinical training in Medicine and Nephrology combined with a Clinical Lecturer post between 2006-2011. He was promoted to Reader in 2015 and to Professor in 2018. He leads the United Kingdom Cardio-Renal Clinical Study Group, as part of the United Kingdom Kidney Research Consortium. He is the Chief Scientist Office Scotland Clinical Lead for Renal Research. His PhD, awarded the Bellahouston Medal for outstanding thesis by medical graduate, was funded by a British Heart Foundation Junior Clinical Fellowship. He graduated in Medicine in 1999 as Brunton Medallist awarded to the highest achieving student that year.
Dr Amanda Mather
University of Sydney